Aurobindo Pharma Gets USFDA Green Light for Generic Xarelto
Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5mg, which is the...
Tag : Aurobindo Pharma Ltd
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine
Pharmaceutical major Aurobindo Pharma Ltd, on 10 April, announced that its subsidiary, CuraTeQ Biologics, has successfully completed the phase 1 Trial of its new bone...
Aurobindo Pharma Falls 3% After US FDA Flags Issues at AP Facility
Shares of Aurobindo Pharma Ltd fell 3% after touching a day’s high of Rs 1,138.05 on 19th February, following the US FDA’s completion of a...
Aurobindo Pharma Shares Slump 2% Despite Telangana Secures VAI Status
Shares of Aurobindo Pharma Ltd slumped 2% on 28 January despite the company declaring that the Telangana active pharmaceutical ingredient (API) factory owned by one...
Aurobindo Pharma Shares Gain as Arm Secures Approval for Cancer Drug
Shares of Aurobindo Pharma Ltd were trading in the green and 1.8% higher on 23 December after the company’s step-down subsidiary, CuraTeQ Biologics s.r.o., announced...
Aurobindo Pharma Arm Receives USFDA Nod for Andhra Pradesh Facility; Shares Down 1%
Shares of Aurobindo Pharma Ltd. dropped 1% from a day’s high of Rs 1,559.90 on 18th September after the company announced that its step-down subsidiary,...
Aurobindo Pharma Arm Gets USFDA Approval
Aurobindo Pharma Ltd on Wednesday 11 September announced that its new injectable facility in Andhra Pradesh has secured its first product approval from the US...
Aurobindo Pharma Shares Drop 6% after Eugia unit-III receives USFDA warning letter
Shares of Aurobindo Pharma Ltd. dropped 6% after touching a day’s high of Rs 1,527 on 16th August, following the company’s disclosure that its Eugia...
Aurobindo Pharma Announces Share Buyback at 6.5% Premium, Shares Trading Flat
Shares of Aurobindo Pharma Ltd. were trading flat during the early trading session, touching a day’s high of Rs 1379 on 18 July despite the...
Aurobindo Pharma Subsidiary’s Telangana Units Gets VAI Status from USFDA
Aurobindo Pharma subsidiary Eugia Pharma’s injectable plant in Telangana was classified by the US Food and Drug Administration (USFDA) in an establishment inspection report as...
